Showing results (1651-1660 of 2,155) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|July 13, 2019
Bayesian approach for cure models with a change-point based on covariate threshold: application to breast cancer dataFarimah Shamsi, Ahmad Reza Baghestani, Fariba BineshJournal of Biopharmaceutical Statistics|February 11, 2005
Effect of dropouts on sample size estimates for test on trends across repeated measurementsChul Ahn, Sin-Ho JungJournal of Biopharmaceutical Statistics|October 31, 2003
Sample size determination based on rank tests in clinical trialsHansheng Wang, Bin Chen, Shein-Chung ChowJournal of Biopharmaceutical Statistics|March 19, 2004
The analysis, interpretation, and presentation of quality of life dataRichard StephensJournal of Biopharmaceutical Statistics|March 19, 2004
Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trialsJ A Sloan, A DueckJournal of Biopharmaceutical Statistics|March 19, 2004
Quality-of-life measurement in clinical trials--the impact of causal variablesPeter M FayersJournal of Biopharmaceutical Statistics|March 19, 2004
Impact of model misspecification at design (and/or) estimation step in population pharmacokinetic studiesYann Merlé, Azzedine Aouimer, Michel TodJournal of Biopharmaceutical Statistics|June 23, 2004
Alternatives for discounting in the analysis of noninferiority trialsSteven M SnapinnJournal of Biopharmaceutical Statistics|June 23, 2004
Hypothesis testing in the "gold standard" design for proving the efficacy of an experimental treatment relative to placebo and a referenceArmin Koch, Joachim RöhmelJournal of Biopharmaceutical Statistics|June 23, 2004
Observation of time-dependent adverse events and the influence of drop-out thereon in long-term safety studies--simulation study under the current practice of post-marketing safety evaluation in JapanMamoru Narukawa, Akifumi Yafune, Masahiro TakeuchiPageof 216